{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:27:24Z","timestamp":1788481644673,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T00:00:00Z","timestamp":1660608000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1136\/ard-2022-222537","type":"journal-article","created":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T17:25:32Z","timestamp":1660670732000},"page":"1678-1684","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Isolated axial disease in psoriatic arthritis and ankylosing spondylitis with psoriasis"],"prefix":"10.1016","volume":"81","author":[{"given":"Timothy S H","family":"Kwok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8297-0275","authenticated-orcid":false,"given":"Vinod","family":"Chandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigil","family":"Haroon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D","family":"Inman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9074-0592","authenticated-orcid":false,"given":"Dafna D","family":"Gladman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard-2022-222537_bib1","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1056\/NEJMra1505557","article-title":"Psoriatic arthritis","volume":"376","author":"Ritchlin","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1136\/ard-2022-222537_bib2","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1136\/ard.2008.094946","article-title":"Treatment recommendations for psoriatic arthritis","volume":"68","author":"Ritchlin","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2022-222537_bib3","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41584-018-0006-8","article-title":"Axial disease in psoriatic arthritis and ankylosing spondylitis: a critical comparison","volume":"14","author":"Feld","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1136\/ard-2022-222537_bib4","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.3899\/jrheum.090412","article-title":"Axial psoriatic arthritis: update on a longterm prospective study","volume":"36","author":"Chandran","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1136\/ard-2022-222537_bib5","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1093\/rheumatology\/kez457","article-title":"Is axial psoriatic arthritis distinct from ankylosing spondylitis with and without concomitant psoriasis?","volume":"59","author":"Feld","year":"2020","journal-title":"Rheumatology"},{"key":"10.1136\/ard-2022-222537_bib6","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/annrheumdis-2016-209853","article-title":"Axial disease in psoriatic arthritis study: defining the clinical and radiographic phenotype of psoriatic spondyloarthritis","volume":"76","author":"Jadon","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2022-222537_bib7","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.3899\/jrheum.171094","article-title":"Influence of axial involvement on clinical characteristics of psoriatic arthritis: analysis from the Corrona psoriatic Arthritis\/Spondyloarthritis registry","volume":"45","author":"Mease","year":"2018","journal-title":"J Rheumatol"},{"key":"10.1136\/ard-2022-222537_bib8","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.3899\/jrheum.140877","article-title":"Updated guidelines for the management of axial disease in psoriatic arthritis","volume":"41","author":"Nash","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1136\/ard-2022-222537_bib9","first-page":"80","article-title":"The effectiveness of a biologic agent on axial manifestations of psoriatic arthritis. A twelve months observational study in a group of patients treated with etanercept","volume":"29","author":"Lubrano","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard-2022-222537_bib10","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1136\/annrheumdis-2020-218808","article-title":"Secukinumab in patients with psoriatic arthritis and axial manifestations: results from the double-blind, randomised, phase 3 maximise trial","volume":"80","author":"Baraliakos","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2022-222537_bib11","doi-asserted-by":"crossref","first-page":"kew390","DOI":"10.1093\/rheumatology\/kew390","article-title":"New grappa and EULAR recommendations for the management of psoriatic arthritis","volume":"56","author":"Coates","year":"2017","journal-title":"Rheumatology"},{"key":"10.1136\/ard-2022-222537_bib12","doi-asserted-by":"crossref","first-page":"700.1","DOI":"10.1136\/annrheumdis-2020-217159","article-title":"EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update","volume":"79","author":"Gossec","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2022-222537_bib13","first-page":"5","article-title":"American College of Rheumatology\/National psoriasis Foundation guideline for the treatment of psoriatic arthritis","volume":"2019","author":"Singh","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/ard-2022-222537_bib14","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2022-222537_bib15","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the new York criteria","volume":"27","author":"van der Linden","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2022-222537_bib16","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s11926-007-0074-2","article-title":"Axial disease in psoriatic arthritis","volume":"9","author":"Gladman","year":"2007","journal-title":"Curr Rheumatol Rep"},{"key":"10.1136\/ard-2022-222537_bib17","first-page":"974","article-title":"Problems with the definition of axial and peripheral disease patterns in psoriatic arthritis","volume":"32","author":"Taylor","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1136\/ard-2022-222537_bib18","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3899\/jrheum.091059","article-title":"Risk factors for axial inflammatory arthritis in patients with psoriatic arthritis","volume":"37","author":"Chandran","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1136\/ard-2022-222537_bib19","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1136\/ard.2011.155044","article-title":"Human leucocyte antigen risk alleles for psoriatic arthritis among patients with psoriasis","volume":"71","author":"Eder","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2022-222537_bib20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/BOR.0000000000000136","article-title":"What have we learned about genetic susceptibility in psoriasis and psoriatic arthritis?","volume":"27","author":"Eder","year":"2015","journal-title":"Curr Opin Rheumatol"},{"key":"10.1136\/ard-2022-222537_bib21","doi-asserted-by":"crossref","first-page":"R185","DOI":"10.1186\/ar2097","article-title":"HLA-C locus alleles may modulate the clinical expression of psoriatic arthritis","volume":"8","author":"Queiro","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard-2022-222537_bib22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/ard.57.3.135","article-title":"Do the radiological changes of classic ankylosing spondylitis differ from the changes found in the spondylitis associated with inflammatory bowel disease, psoriasis, and reactive arthritis?","volume":"57","author":"Helliwell","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2022-222537_bib23","first-page":"2667","article-title":"Inflammatory eye, skin, and bowel disease in spondyloarthritis: genetic, phenotypic, and environmental factors","volume":"28","author":"Brophy","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1136\/ard-2022-222537_bib24","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1136\/annrheumdis-2012-202922","article-title":"Ankylosing spondylitis patients with and without psoriasis do not differ in disease phenotype","volume":"72","author":"Machado","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2022-222537_bib25","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/BOR.0000000000000609","article-title":"Psoriatic spondylitis or ankylosing spondylitis with psoriasis: same or different?","volume":"31","author":"Chandran","year":"2019","journal-title":"Curr Opin Rheumatol"},{"key":"10.1136\/ard-2022-222537_bib26","doi-asserted-by":"crossref","first-page":"e677","DOI":"10.1016\/S2665-9913(21)00141-7","article-title":"How should we define disease and outcomes in axial psoriatic arthritis?","volume":"3","author":"Coates","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"10.1136\/ard-2022-222537_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1759720X211057975","article-title":"Axial involvement in psoriatic arthritis cohort (AXIS): the protocol of a joint project of the assessment of spondyloarthritis International Society (ASAS) and the group for research and assessment of psoriasis and psoriatic arthritis (GRAPPA)","volume":"13","author":"Poddubnyy","year":"2021","journal-title":"Ther Adv Musculoskelet Dis"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672408734X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672408734X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard-2022-222537","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T09:26:43Z","timestamp":1749806803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000349672408734X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S000349672408734X"],"URL":"https:\/\/doi.org\/10.1136\/ard-2022-222537","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isolated axial disease in psoriatic arthritis and ankylosing spondylitis with psoriasis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard-2022-222537","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 \u00a9 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}